Fred Imbert is a CNBC News Associate covering markets.
Prior to CNBC, Imbert worked as a business consultant in San Juan, Puerto Rico and held an internship at the Central New York Business Journal where he covered small and local businesses.
Imbert graduated from Syracuse University with a Bachelor of Arts degree in Newspaper Journalism and Political Science.
Follow Fred Imbert on Twitter @foimbert
U.S. equities closed mostly flat ahead of Christmas, as the Dow tried again to reach the psychologically important level of 20,000.
Synergy Pharmaceuticals skyrocketed after the firm reported positive trial results for an irritable bowel syndrome drug.
Stocks fell as investors digested a series of economic data, while the Dow struggled to reach a key psychological level.
U.S. equities fell slightly on Wednesday, with real estate lagging, as the Dow Jones industrial average failed to reach 20,000.
Stocks rose as investors remained unfazed by geopolitical tensions, while the Dow Jones industrial average kept marching toward 20,000.
U.S. stocks rose on Thursday as investors digested a slew of economic data and the Federal Reserve's decision to raise interest rates.
Rising yields in the United States could make it harder for Beijing to keep managing its tremendous debt problem.
U.S. stocks fell in choppy trade Wednesday after the Federal Reserve raise rates for the second time in a decade.
Stocks closed higher as investors kept an eye on a key Fed meeting, while the Dow closed in on another milestone.